期刊文献+

阿托伐他汀联合快步运动对颈动脉斑块逆转的影响 被引量:8

Effect of atorvastatin combined with brisk walking on carotid plaque reversal
下载PDF
导出
摘要 目的研究阿托伐他汀联合快步运动对动脉粥样斑块逆转的效果。方法将120例动脉粥样硬化患者分为他汀组和联合组。他汀组给予阿托伐他汀钙片20 mg/d(北京阿乐)口服,联合组在阿托伐他汀钙片20mg/d口服基础上联合快步运动(4~5天/周),随访2年。采用颈部血管超声评估颈部血管动脉硬化斑块面积、颈动脉内膜中膜厚度(IMT)、稳定斑块率来评估斑块逆转效果。结果联合组在降低甘油三酯(TG)、总胆固醇(TC)、低密度脂蛋白胆固醇(LDLC)水平,提高高密度脂蛋白胆固醇(HDLC)方面优于他汀组。联合组对颈动脉斑块IMT、最大斑块面积、斑块数量及提高稳定斑块率方面优于他汀组。结论他汀类药物联合快步有氧运动能够降低LDLC、TC、TG水平,提高HDLC的水平及功能,增加斑块稳定性,具有逆转斑块的作用,且随着时间延长,抗动脉硬化作用增强。 Aim To study the effect of atorvastatin combined with brisk walking on atherosclerotic plaques reversal. Methods 120 atherosclerotic patients were divided into statin group and combined group. Carotid atherosclerotic plaque area,carotid intima-media thickness and stable plaque rate were used to evaluate plaque reversal effect. Statin group was given atorvastatin calcium tablets 20 mg/d( Beijing Ale) orally. The combined group took a quick walk( 4 ~ 5 days/week) on the basis of atorvastatin calcium tablets 20 mg/d. The follow-up was 2 years. Results The combined group was superior to statin group in reducing TG,TC,LDLC and increasing HDLC. The combined group was superior to statin group in carotid artery plaque IMT,maximum plaque area,plaque number and stable plaque rate. Conclusion The combination of statins and fast aerobic exercise can improve the anti-atherosclerotic effect and reduce the level and function of LDLC,TC and TG,increase the level and function of HDLC,increase the stability of plaque,reverse the plaque effect,and increase the anti-arteriosclerosis as the time prolongs.
出处 《中国动脉硬化杂志》 CAS 2018年第10期1041-1044,共4页 Chinese Journal of Arteriosclerosis
关键词 动脉硬化 颈动脉斑块 他汀 快步运动 斑块逆转 arteriosclerosis carotid plaque statin fast walking reverse plaque
  • 相关文献

参考文献5

二级参考文献109

  • 1RIDKER PM, DANIELSON E,FONSECA FA, et al. for the JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein [ J]. N Engl J Med, 2008, 359(21):2195-2207.
  • 2DAHLOF B, SEVER PS, POULTER NR. for the ASCOT investigators. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA) : a multicentre randomised controlled trial[J]. Lancet, 2005,366(9488) :895 -906.
  • 3COLHOUN HM, BETTERIDGE DJ, DURRINGTON PN,et al. CARDS investigators. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study ( CARDS ) : multicentre randomised placebo-controlled trial [ J ]. Lancet, 2004,364 ( 9435 ) :685-696.
  • 4The Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes[ J]. N Engl J Med,2008,358 ( 24 ) : 2545-2559.
  • 5BAIGENT C, LANDRAY MJ, REITH C,et al. SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease ( Study of Heart and Renal Protection) : a randomised placebo-controlled trial[ J]. Lancet, 2011,377(9784) :2181 -2192.
  • 6Saar Aharoni,Michael Aviram,Bianca Fuhrman.Paraoxonase 1 (PON1) reduces macrophage inflammatory responses[J]. Atherosclerosis . 2013 (2)
  • 7Jonathan E. Feig,Bernd Hewing,Jonathan D. Smith,Stanley L. Hazen,Edward A. Fisher.High-Density Lipoprotein and Atherosclerosis Regression: Evidence From Preclinical and Clinical Studies[J]. Circulation Research . 2014 (1)
  • 8Marina Cuchel,Daniel J. Rader.Macrophage Reverse Cholesterol Transport: Key to the Regression of Atherosclerosis?[J]. Circulation . 2006 (21)
  • 9Yang Yu,Shoudong Guo,Yumei Feng,Lei Feng,Yingjie Cui,Guohua Song,Tian Luo,Ke Zhang,Yiwei Wang,Xian-Cheng Jiang,Shucun Qin.??Phospholipid Transfer Protein Deficiency Decreases the Content of S1P in HDL via the Loss of its Transfer Capability(J)Lipids . 2014 (2)
  • 10Thimoteus Speer,Lucia Rohrer,Przemyslaw Blyszczuk,Rukshana Shroff,Kira Kuschnerus,Nicolle Kr?nkel,Gabriela Kania,Stephen Zewinger,Alexander Akhmedov,Yi Shi,Tina Martin,Damir Perisa,Stephan Winnik,Maja F. Müller,Urban Sester,Gabriel Wernicke,Andreas Jung,Ursula Gutteck,Urs Eriksson,Jürgen Geisel,John Deanfield,Arnold von Eckardstein,Thomas F. Lüscher,Danilo Fliser,Ferdinand H. Bahlmann,Ulf Landmesser.??Abnormal High-Density Lipoprotein Induces Endothelial Dysfunction via Activation of Toll-Like Receptor-2(J)Immunity . 2013

共引文献38

同被引文献135

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部